Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 66, Issue 5, Pages 1556-1569
Publisher
Wiley
Online
2017-06-16
DOI
10.1002/hep.29318
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low-level viremia and the increased risk of hepatocellular carcinoma in patients receiving entecavir treatment
- (2016) Jung Hee Kim et al. HEPATOLOGY
- Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B
- (2015) W. Ray Kim et al. CANCER
- AASLD guidelines for treatment of chronic hepatitis B
- (2015) Norah A. Terrault et al. HEPATOLOGY
- Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
- (2015) George V. Papatheodoridis et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
- (2015) JOURNAL OF HEPATOLOGY
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- Extrahepatic Platelet-Derived Growth Factor-β, Delivered by Platelets, Promotes Activation of Hepatic Stellate Cells and Biliary Fibrosis in Mice
- (2014) Shuhei Yoshida et al. GASTROENTEROLOGY
- Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma
- (2013) Giovanni Sitia et al. JOURNAL OF HEPATOLOGY
- Chemopreventive strategies in hepatocellular carcinoma
- (2013) Siddharth Singh et al. Nature Reviews Gastroenterology & Hepatology
- High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load
- (2012) Tai–Chung Tseng et al. GASTROENTEROLOGY
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
- (2012) Tetsuya Hosaka et al. HEPATOLOGY
- Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma
- (2012) Vikrant V. Sahasrabuddhe et al. JNCI-Journal of the National Cancer Institute
- Platelets harness the immune response to drive liver cancer
- (2012) M. K. Maini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
- (2012) G. Sitia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Statin Use and the Risk of Liver Cancer: A Population-Based Case–Control Study
- (2010) Hui-Fen Chiu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Proton Pump Inhibitor and Clopidogrel Interaction: Fact or Fiction?
- (2009) Loren Laine et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
- (2009) Hashem B. El–Serag et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now